参考文献/References:
[1] Maurer AH, Charkes ND. Radioiodine treatment for nontoxic multinodular goiter[J]. J Nucl Med, 1999, 40:1313~1316.
[2] Huysmans D, Hermus A, Edelbroek M, et al.Radioiodine for nontoxic multinodular goiter[J].Thyroid, 1997, 7:235~239.
[3] de Klerk JM H, van Isselt JW, van Dijk JW, et al.Iodine-131 therapy in sporadic nontoxic goiter[J]. J Nucl Med, 1997, 38:372~376.
[4] Feldkamp J, Seppel T, Becker A, et al. Iodine or L-thyrxine to prevent recurrent goiter in an iodine-deficient area:prospective sonographic study[J]. World J Surg, 1997, 21:10~14.
[5] Hegedüs L, Bennedbæk FN. Radioiodine for non-toxic diffuse goiter[J]. Lancet, 1997, 350:409~410.
[6] Seiler CA, Glaser C, Wagner HE. Thyroid gland surgery in an endemic region[J]. World J Surg, 1996,20:593~596.
[7] Nygaard B, Faber J, Veje A, et al. Thyroid volume and function after131 I treatment of diffuse non-toxic goiter[J]. Clin Endocrinol, 1997, 47:493~496.
[8] Hermus ADR, Huysmans DA. Treatment of benign nodular thyroid disease[J]. N Engl J Med, 1998, 338:1438~1447.
[9] Huysmans DAKC, Buijs WCAM, vande Ven MTP, et al. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters[J]. J Nucl Med, 1996,37:2072~2079.
相似文献/References:
[1]卢倜章.131I治疗甲状腺疾病的研究趋向[J].国际放射医学核医学杂志,2000,24(3):97.
LU Ti-zhang.Current trend of research on 131I therapy for thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(3):97.